Recommended test if serology is used to aid in the diagnosis of cerebral blastomycosis.
Semi-Quantitative Enzyme-Linked Immunosorbent Assay/Qualitative Immunodiffusion
New York DOH Approval Status
Transfer 1 mL CSF to an ARUP Standard Transport Tube. (Min: 0.3 mL)
Other body fluids. Contaminated, hemolyzed, xanthochromic, or severely lipemic specimens.
Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
|3000230||Fungal Antibodies with Reflex to Blastomyces dermatitidis Antibodies by Immunodiffusion, CSF||0.9 IV or less: Negative
1.0-1.4 IV: Equivocal
1.5 IV or greater: Positive
|Blastomyces Ab by Immunodiffusion, CSF||None Detected|
Refer to Report
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Negative fungal serology does not rule out the possibility of current infection. If Blastomyces antibodies are equivocal or positive by EIA then Blastomyces Immunodiffusion will be added. Additional charges apply.
86612; if reflexed, add 86612
|Component Test Code*||Component Chart Name||LOINC|
|3000233||Blastomyces Antibody by EIA, CSF||13201-9|